1. Home
  2. TMDE vs SNTI Comparison

TMDE vs SNTI Comparison

Compare TMDE & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMDE

TMD Energy Limited Ordinary Shares

HOLD

Current Price

$1.24

Market Cap

21.7M

Sector

Energy

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.93

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDE
SNTI
Founded
2016
2016
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.7M
24.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TMDE
SNTI
Price
$1.24
$0.93
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
2.9M
92.8K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.31
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.77
52 Week High
$4.77
$5.10

Technical Indicators

Market Signals
Indicator
TMDE
SNTI
Relative Strength Index (RSI) 45.80 54.71
Support Level $0.64 $0.78
Resistance Level $1.37 $0.93
Average True Range (ATR) 0.24 0.05
MACD -0.03 0.01
Stochastic Oscillator 14.75 83.27

Price Performance

Historical Comparison
TMDE
SNTI

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: